Follow The Filings

COCO Vita Coco Co. Inc.

Consumer Staples, filed as VITA COCO CO INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $3.4M
  • 1 reduce

In 2026 Q2 Lee Ainslie trimmed Vita Coco.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Lee Ainslie, Maverick Capital). Not free-float ownership.

  1. Lee Ainslie Reduce 0.03%

Who owns COCO

Sorted by value, long equity only, as of 2026 Q2.

History
Lee Ainslie, Maverick Capital 0.03%, was 0.04% Reduce −32.9% 51,659 $3.4M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by COCO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All COCO insider trades
  • None no insider bought on the open market
  • $1.5M sold by 1 insider outside a trading plan
  • $87.4M sold by 10 insiders under 10b5-1 plans
  1. Kenneth Sadowsky Director
    Planned sale
    $323K 3,900 shares at $82.92 0.7% of stake
    Traded Jun 17 Filed Jun 18
    ↗
  2. Ira Liran Director
    Planned sale
    $11.9M 148,074 shares at $80.31
    Traded Jun 12 Filed Jun 15
    ↗
  3. Ira Liran Director
    Planned sale
    $15.2M 191,926 shares at $79.14
    Traded Jun 11 Filed Jun 12
    ↗
  4. Jonathan Burth COO
    Planned sale
    $2.4M 30,000 shares at $80.00 34% of stake
    Traded Jun 11 Filed Jun 12
    ↗
  5. Charles Van Es Chief Commercial Officer
    Planned sale
    $604K 8,045 shares at $75.05 12% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  6. Kenneth Sadowsky Director
    Planned sale
    $302K 3,900 shares at $77.48 0.7% of stake
    Traded May 20 Filed May 21
    ↗
  7. Jonathan Burth COO
    Planned sale
    $2.2M 30,000 shares at $75.00 34% of stake
    Traded May 12 Filed May 13
    ↗
  8. Jonathan Burth COO
    Planned sale
    $1.4M 20,000 shares at $70.00 26% of stake
    Traded May 8 Filed May 11
    ↗
  9. Charles Van Es Chief Commercial Officer
    Planned sale
    $599K 8,561 shares at $70.00 11% of stake
    Traded May 8 Filed May 11
    ↗
  10. Charles Van Es Chief Commercial Officer
    Planned sale
    $134K 2,000 shares at $66.87 2.6% of stake
    Traded May 1 Filed May 4
    ↗
  11. Michael Kirban Chair
    Planned sale
    $3.4M 50,000 shares at $68.00 8.8% of stake
    Traded Apr 30 Filed May 1
    ↗
  12. Jonathan Burth COO
    Planned sale
    $3.9M 60,000 shares at $65.00 51% of stake
    Traded Apr 29–30 Filed May 1
    ↗
  13. Martin Roper CEO
    Planned sale
    $2.5M 45,544 shares at $54.84 13% of stake
    Traded Apr 28–29 Filed Apr 30
    ↗
  14. Martin Roper CEO
    Planned sale
    $2.5M 50,000 shares at $50.00 14% of stake
    Traded Apr 24–27 Filed Apr 28
    ↗
  15. Martin Roper CEO
    Planned sale
    $1.2M 25,000 shares at $50.00 7.7% of stake
    Traded Apr 16 Filed Apr 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 38 option exercises, 27 share withholdings for taxes, 14 stock grants, and 3 gifts.

Congress

2 members of Congress traded COCO in the last three years: 5 buys and 1 sale. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Sep 17 filed Oct 12
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jul 10 filed Sep 4
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Mar 3 filed Apr 7
  4. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Dec 11, 2025 filed Jan 12
  5. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Mar 4, 2025 filed Apr 7, 2025
  6. Josh Gottheimer D-NJ-5Joint Buy $1K–$15K Dec 1, 2023 filed Jan 7, 2024

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.01,3.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K/A 5.02 Filing Doc

Source: SEC EDGAR submissions, updated about 21 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $493.61M $516.01M $609.78M
Gross profit $180.73M $198.78M $222.6M
Gross margin * 36.6% 38.5% 36.5%
Net income $46.63M $55.95M $71.32M
Net margin * 9.4% 10.8% 11.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $262.94M $341.29M $421.44M
Total non-current assets * $22.74M $21.09M $39.72M
Total assets $285.68M $362.38M $461.16M
Total current liabilities $82.58M $103.27M $116.43M
Total non-current liabilities * $0.66M $0.298M $13.18M
Total equity $202.44M $258.82M $331.54M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $107.16M $42.9M $47.17M
Cash from investing -$0.594M -$0.974M -$8.25M
Cash from financing $6.29M -$8.3M -$7.53M
Net change in cash $113.24M $33.07M $32.22M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.